Mucosal adjuvanticity and mucosal booster effect of colibactin-depleted probiotic Escherichia coli membrane vesicles

References

• Collaborators GBDAR. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;400(10369):2221–11. doi:10.1016/S0140-6736(22)02185-7. PMID: 36423648.
   PubMed Web of Science ®Google Scholar
• LeBlanc JJ, ElSherif M, Ye L, MacKinnon-Cameron D, Li L, Ambrose A, Hatchette TF, Lang AL, Gillis H, Martin I, et al. Burden of vaccine-preventable pneumococcal disease in hospitalized adults: a Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study. Vaccine. 2017;35(29):3647–3654. doi:10.1016/j.vaccine.2017.05.049. PMID: 28554501.
   PubMed Web of Science ®Google Scholar
• Shi T, Denouel A, Tietjen AK, Lee JW, Falsey AR, Demont C, Nyawanda BO, Cai B, Fuentes R, Stoszek SK, et al. Global and regional burden of hospital admissions for pneumonia in older adults: a systematic review and meta-analysis. J Infect Dis. 2020;222(Supplement_7):SS570–SS576. doi:10.1093/infdis/jiz053. PMID: 30849172.
   Google Scholar
• Afkhami S, D’Agostino MR, Zhang A, Stacey HD, Marzok A, Kang A, Singh R, Bavananthasivam J, Ye G, Luo X, et al. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell. 2022;185(5):896–915.e19. doi:10.1016/j.cell.2022.02.005. PMID: 35180381.
   PubMed Web of Science ®Google Scholar
• Ladhani SN, Andrews N, Parikh SR, Campbell H, White J, Edelstein M, Bai X, Lucidarme J, Borrow R, Ramsay ME. Vaccination of infants with meningococcal group B vaccine (4CMenB) in England. N Engl J Med. 2020;382(4):309–317. doi:10.1056/NEJMoa1901229. PMID: 31971676.
   PubMed Web of Science ®Google Scholar
• Behnsen J, Deriu E, Sassone-Corsi M, Raffatellu M. Probiotics: properties, examples, and specific applications. Cold Spring Harb Perspect Med. 2013;3(3):a010074. doi: 10.1101/cshperspect.a010074. PMID: 23457295.
   PubMed Web of Science ®Google Scholar
• Rosenthal JA, Huang CJ, Doody AM, Leung T, Mineta K, Feng DD, Wayne EC, Nishimura N, Leifer C, DeLisa MP, et al. Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles. PLOS ONE. 2014;9(11):e112802. doi:10.1371/journal.pone.0112802. PMID: 25426709.
   PubMed Web of Science ®Google Scholar
• Sturm A, Rilling K, Baumgart DC, Gargas K, Abou-Ghazale T, Raupach B, Eckert J, Schumann RR, Enders C, Sonnenborn U, et al. Escherichia coli nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. Infect Immun. 2005;73(3):1452–1465. doi:10.1128/IAI.73.3.1452-1465.2005. PMID: 15731043.
   PubMed Web of Science ®Google Scholar
• Canas MA, Fabrega MJ, Gimenez R, Badia J, Baldoma L. Outer membrane vesicles from probiotic and commensal Escherichia coli Activate NOD1-mediated immune responses in intestinal epithelial cells. Front Microbiol. 2018;9:498. doi:10.3389/fmicb.2018.00498. PMID: 29616010.
   PubMed Web of Science ®Google Scholar
• Nakao R, Kobayashi H, Iwabuchi Y, Kawahara K, Hirayama S, Ramstedt M, Sasaki Y, Kataoka M, Akeda Y, Ohnishi M. A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles. NPJ Vaccines. 2022;7(1):153. doi:10.1038/s41541-022-00572-z. PMID: 36435869.
   PubMed Web of Science ®Google Scholar
• Raeven RHM, Rockx-Brouwer D, Kanojia G, van der Maas L, Bindels THE, Ten Have R, van Riet E, Metz B, Kersten GFA. Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses. Sci Rep. 2020;10(1):7396. doi:10.1038/s41598-020-63998-2. PMID: 32355188.
   PubMed Web of Science ®Google Scholar
• Grund M, Choi SJ, Powell L, Lukomski S. Intranasal immunization with a Bucl8-based vaccine ameliorates bacterial burden and pathological inflammation, and promotes an IgG2a/b dominant response in an outbred mouse model of Burkholderia infection. Front Immunol. 2023;14:1177650. doi:10.3389/fimmu.2023.1177650. PMID: 37545515.
   PubMed Web of Science ®Google Scholar
• Aguilo N, Alvarez-Arguedas S, Uranga S, Marinova D, Monzon M, Badiola J, Martin C. Pulmonary but not subcutaneous delivery of BCG vaccine confers protection to tuberculosis-susceptible mice by an interleukin 17-dependent mechanism. J Infect Dis. 2016;213(5):831–839. doi:10.1093/infdis/jiv503. PMID: 26494773.
   PubMed Web of Science ®Google Scholar
• Yu J, Li B, Chen X, Lu J, Wang D, Gu T, Kong W, Wu Y, Freitag NE. Comparison of immunogenicity and protection of two pneumococcal protein vaccines based on PsaA and PspA. Infect Immun. 2018;86(6). doi:10.1128/IAI.00916-17. PMID: 29610257.
   Web of Science ®Google Scholar
• Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, Gurjao C, Manders F, Dalmasso G, Stege PB, et al. Mutational signature in colorectal cancer caused by genotoxic pks(+) E. coli. Nature. 2020;580(7802):269–273. doi:10.1038/s41586-020-2080-8. PMID: 32106218.
   PubMed Web of Science ®Google Scholar
• Dziubanska-Kusibab PJ, Berger H, Battistini F, Bouwman BAM, Iftekhar A, Katainen R, Cajuso T, Crosetto N, Orozco M, Aaltonen LA, et al. Colibactin DNA-damage signature indicates mutational impact in colorectal cancer. Nat Med. 2020;26(7):1063–1069. doi:10.1038/s41591-020-0908-2. PMID: 32483361.
   PubMed Web of Science ®Google Scholar
• Nougayrede JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Buchrieser C, Hacker J, Dobrindt U, Oswald E. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313(5788):848–851. doi:10.1126/science.1127059. PMID: 16902142.
   PubMed Web of Science ®Google Scholar
• Homburg S, Oswald E, Hacker J, Dobrindt U. Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol Lett. 2007;275(2):255–262. doi: 10.1111/j.1574-6968.2007.00889.x. PMID: 17714479.
   PubMed Web of Science ®Google Scholar
• Nougayrede JP, Chagneau CV, Motta JP, Bossuet-Greif N, Belloy M, Taieb F, Gratadoux JJ, Thomas M, Langella P, Oswald E. A toxic friend: genotoxic and mutagenic activity of the probiotic strain Escherichia coli nissle 1917. mSphere. 2021;6(4):e0062421. doi:10.1128/mSphere.00624-21. PMID: 34378987.
   PubMed Web of Science ®Google Scholar
• Nissle A. Über die Grundlagen einer neuen ursächlichen Bekämpfung der pathologischen Darmflora. Dtsch Med Wochenschr. 1916;42:1181–1184.
   Google Scholar
• Hirayama S, Nakao R. Glycine significantly enhances bacterial membrane vesicle production: a powerful approach for isolation of LPS-reduced membrane vesicles of probiotic Escherichia coli. Microb Biotechnol. 2020;13(4):1162–1178. doi: 10.1111/1751-7915.13572. PMID: 32348028.
   PubMed Web of Science ®Google Scholar
• Beld J, Sonnenschein EC, Vickery CR, Noel JP, Burkart MD. The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life. Nat Prod Rep. 2014;31(1):61–108. doi: 10.1039/c3np70054b. PMID: 24292120.
   PubMed Web of Science ®Google Scholar
• Cougnoux A, Gibold L, Robin F, Dubois D, Pradel N, Darfeuille-Michaud A, Dalmasso G, Delmas J, Bonnet R. Analysis of structure-function relationships in the colibactin-maturating enzyme ClbP. J Mol Biol. 2012;424(3–4):203–214. doi:10.1016/j.jmb.2012.09.017. PMID: 23041299.
   PubMed Web of Science ®Google Scholar
• Dubois D, Baron O, Cougnoux A, Delmas J, Pradel N, Boury M, Bouchon B, Bringer MA, Nougayrede JP, Oswald E, et al. ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides. J Biol Chem. 2011;286(41):35562–35570. doi:10.1074/jbc.M111.221960. PMID: 21795676.
   PubMed Web of Science ®Google Scholar
• Brotherton CA, Balskus EP. A prodrug resistance mechanism is involved in colibactin biosynthesis and cytotoxicity. J Am Chem Soc. 2013;135(9):3359–3362. doi: 10.1021/ja312154m. PMID: 23406518.
   PubMed Web of Science ®Google Scholar
• Bossuet-Greif N, Dubois D, Petit C, Tronnet S, Martin P, Bonnet R, Oswald E, Nougayrede JP. Escherichia coli ClbS is a colibactin resistance protein. Mol Microbiol. 2016;99(5):897–908. doi: 10.1111/mmi.13272. PMID: 26560421.
   PubMed Web of Science ®Google Scholar
• Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000;97(12):6640–6645. doi: 10.1073/pnas.120163297. PMID: 10829079.
   PubMed Web of Science ®Google Scholar
• Price NL, Goyette-Desjardins G, Nothaft H, Valguarnera E, Szymanski CM, Segura M, Feldman MF. Glycoengineered outer membrane vesicles: a novel platform for bacterial vaccines. Sci Rep. 2016;6:24931. doi:10.1038/srep24931. PMID: 27103188.
   PubMed Web of Science ®Google Scholar
• Wang RF, Kushner SR. Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene. 1991;100:195–199. doi:10.1016/0378-1119(91)90366-J. PMID: 2055470.
   PubMed Web of Science ®Google Scholar
• Imohl M, Reinert RR, Ocklenburg C, van der Linden M. Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease. J Clin Microbiol. 2010;48(4):1291–1296. doi:10.1128/JCM.01937-09. PMID: 20107087.
   PubMed Web of Science ®Google Scholar
• Hirayama S, Nakao R. Glycine induction method: effective production of immunoactive bacterial membrane vesicles with low endotoxin content. Methods Mol Biol. 2022;2414:207–226. doi:10.1007/978-1-0716-1900-1_13. PMID: 34784040.
   PubMedGoogle Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72(1–2):248–254. doi: 10.1016/0003-2697(76)90527-3. PMID: 942051.
   PubMed Web of Science ®Google Scholar
• Nakao R, Myint SL, Wai SN, Uhlin BE. Enhanced biofilm formation and membrane vesicle release by Escherichia coli expressing a commonly occurring plasmid gene, kil. Front Microbiol. 2018;9:2605. doi:10.3389/fmicb.2018.02605. PMID: 30464758.
   PubMed Web of Science ®Google Scholar
• Nakao R, Hirayama S, Yamaguchi T, Senpuku H, Hasegawa H, Suzuki T, Akeda Y, Ohnishi M. A bivalent outer membrane vesicle-based intranasal vaccine to prevent infection of periodontopathic bacteria. Vaccine. 2023;41(30):4369–4383. doi:10.1016/j.vaccine.2023.05.058. PMID: 37302966.
   PubMed Web of Science ®Google Scholar
• Hirayama Y, Tsunematsu Y, Yoshikawa Y, Tamafune R, Matsuzaki N, Iwashita Y, Ohnishi I, Tanioka F, Sato M, Miyoshi N, et al. Activity-based probe for screening of high-colibactin producers from clinical samples. Org Lett. 2019;21(12):4490–4494. doi:10.1021/acs.orglett.9b01345. PMID: 31192617.
   PubMed Web of Science ®Google Scholar
• Zhou T, Hirayama Y, Tsunematsu Y, Suzuki N, Tanaka S, Uchiyama N, Goda Y, Yoshikawa Y, Iwashita Y, Sato M, et al. Isolation of new colibactin metabolites from wild-type Escherichia coli and in situ trapping of a mature colibactin derivative. J Am Chem Soc. 2021;143(14):5526–5533. doi:10.1021/jacs.1c01495. PMID: 33787233.
   PubMed Web of Science ®Google Scholar
• Lapuente D, Fuchs J, Willar J, Vieira Antao A, Eberlein V, Uhlig N, Issmail L, Schmidt A, Oltmanns F, Peter AS, et al. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization. Nat Commun. 2021;12(1):6871. doi:10.1038/s41467-021-27063-4. PMID: 34836955.
   PubMed Web of Science ®Google Scholar
• Zhou R, Wang P, Wong YC, Xu H, Lau SY, Liu L, Mok BW, Peng Q, Liu N, Woo KF, et al. Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models. EBioMedicine. 2022;75:103762. doi:10.1016/j.ebiom.2021.103762. PMID: 34942445.
   PubMed Web of Science ®Google Scholar
• Rappuoli R. Glycoconjugate vaccines: principles and mechanisms. Sci Trans Med. 2018;10(456). doi:10.1126/scitranslmed.aat4615. PMID: 30158151.
   PubMed Web of Science ®Google Scholar
• Vu MN, Kelly HG, Kent SJ, Wheatley AK. Current and future nanoparticle vaccines for COVID-19. EBioMedicine. 2021;74:103699. doi:10.1016/j.ebiom.2021.103699. PMID: 34801965.
   PubMed Web of Science ®Google Scholar
• Ohtsuka J, Imai M, Fukumura M, Maeda M, Eguchi A, Ono R, Maemura T, Ito M, Yamayoshi S, Kataoka Y, et al. Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2. iScience. 2021;24(12):103379. doi:10.1016/j.isci.2021.103379. PMID: 34805782.
   PubMed Web of Science ®Google Scholar
• Martinez FG, Zielke RA, Fougeroux CE, Li L, Sander AF, Sikora AE, Kline KA. Development of a tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved Neisseria gonorrhoeae SliC antigen that blocks human lysozyme. Infect Immun. 2023;91(12):e0024523. doi:10.1128/iai.00245-23. PMID: 37916806.
   PubMed Web of Science ®Google Scholar
• Eom GD, Chu KB, Kang HJ, Kim MJ, Yoon KW, Mao J, Lee SH, Ahmed MA, Moon EK, Quan FS, et al. Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall protein. PLOS ONE. 2023;18(4):e0283928. doi:10.1371/journal.pone.0283928. PMID: 37104285.
   PubMed Web of Science ®Google Scholar
• Furukawa A, Kamishikiryo J, Mori D, Toyonaga K, Okabe Y, Toji A, Kanda R, Miyake Y, Ose T, Yamasaki S, et al. Structural analysis for glycolipid recognition by the C-type lectins mincle and MCL. Proc Natl Acad Sci USA. 2013;110(43):17438–17443. doi:10.1073/pnas.1312649110. PMID: 24101491.
   PubMed Web of Science ®Google Scholar
• Jain S, Chang AM, Singh M, McLean JS, Coats SR, Kramer RW, Darveau RP. Identification of PGN_1123 as the gene encoding lipid a deacylase, an enzyme required for toll-like receptor 4 evasion, in Porphyromonas gingivalis. J Bacteriol. 2019;201(11). doi:10.1128/JB.00683-18. PMID: 30782639.
   Web of Science ®Google Scholar
• Boyaka PN. Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems. J Immunol. 2017;199(1):9–16. doi: 10.4049/jimmunol.1601775. PMID: 28630108.
   PubMed Web of Science ®Google Scholar
• Johansen FE, Kaetzel CS. Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal Immunol. 2011;4(6):598–602. doi: 10.1038/mi.2011.37. PMID: 21956244.
   PubMed Web of Science ®Google Scholar
• Narciso AR, Iovino F, Thorsdottir S, Mellroth P, Codemo M, Spoerry C, Righetti F, Muschiol S, Normark S, Nannapaneni P, et al. Membrane particles evoke a serotype-independent cross-protection against pneumococcal infection that is dependent on the conserved lipoproteins MalX and PrsA. Proc Natl Acad Sci USA. 2022;119(23):e2122386119. doi:10.1073/pnas.2122386119. PMID: 35648835.
   PubMed Web of Science ®Google Scholar
• Daniels CC, Briles TC, Mirza S, Hakansson AP, Briles DE. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae. Microb Pathog. 2006;40(5):228–233. doi:10.1016/j.micpath.2006.01.007. PMID: 16540281.
   PubMed Web of Science ®Google Scholar
• Shainheit MG, Mule M, Camilli A, Pirofski L. The core promoter of the capsule operon of Streptococcus pneumoniae is necessary for colonization and invasive disease. Infect Immun. 2014;82(2):694–705. doi:10.1128/IAI.01289-13. PMID: 24478084.
   PubMed Web of Science ®Google Scholar
• Spencer BL, Saad JS, Shenoy AT, Orihuela CJ, Nahm MH, Freitag NE. Position of O-Acetylation within the capsular repeat unit impacts the biological properties of pneumococcal serotypes 33A and 33F. Infect Immun. 2017;85(7). doi:10.1128/IAI.00132-17. PMID: 28438972.
   Web of Science ®Google Scholar